New study combines app support and antibiotic after sex to fight HIV and STIs in youth

NCT ID NCT07510048

Not yet recruiting Prevention Sponsor: Westat Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests a mobile health program called PrEP Choice to help young people ages 13-24 start and stick with HIV prevention pills or shots. It also looks at whether taking the antibiotic doxycycline after sex (DoxyPEP) can prevent other sexually transmitted infections. About 200 participants who are at higher risk for HIV will be followed for up to 18 months to see if these tools work and are easy to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV HIV PREVENTION STIS STIS PREVENTION

Contacts and locations

Locations

Children's National Medical Center

Washington D.C., District of Columbia, 20010, United States
San Francisco Department of Public Health

San Francisco, California, 94102, United States
St. Jude Children's Research Hospital

Memphis, Tennessee, 38015, United States
Tulane University

New Orleans, Louisiana, 70112, United States
University Illinois Chicago

Chicago, Illinois, 60612, United States
University of South Florida

Tampa, Florida, 33612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.